Cover

Allergy and Asthma in Modern Society: A Scientific Approach

Editor(s): Crameri R. (Davos) 
Table of Contents
Vol. 91, No. , 2006
Section title: Paper
Crameri R (ed): Allergy and Asthma in Modern Society: A Scientific Approach. Chem Immunol Allergy. Basel, Karger, 2006, vol 91, pp 134-146
(DOI:10.1159/000090277)

Structural Features of Allergenic Molecules

Aalberse R.
Sanquin Research at CLB and Karl Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 12/8/2005
Cover Date: 2006

Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-8000-7 (Print)
eISBN: 978-3-318-01266-8 (Online)

Abstract

In this paper the relation between protein allergenicity (the capacity to induce IgE antibody production or the capacity to activate mast cells sensitized with IgE antibodies induced by a cross-reactive allergen) and protein structure is discussed. While cross-reactivity is to a large degree predictable from primary sequence comparisons, the IgE-inducing capacity is mostly determined by factors other than the primary sequence. Two routes to IgE are discussed: (1) the atopic route (used by allergens from pollen and mites) in which a direct switch from μ to ε is common and (2) the ‘modified Th2’ route (used by allergens from pets) in which the class switch to IgE is often preceded by a switch to IgG4. According to this working hypothesis, the choice between these two routes is determined at the level of the germinal center activity.


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 12/8/2005
Cover Date: 2006

Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-8000-7 (Print)
eISBN: 978-3-318-01266-8 (Online)


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.